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Abstract 
Background: In recent years, the Kraepelinian dichotomy has been challenged in light of evidence on 
shared genetic and environmental factors for schizophrenia and bipolar disorder, but empirical 
efforts to identify a transdiagnostic phenotype of psychosis remain remarkably limited.  
Aims: To investigate whether schizophrenia spectrum and bipolar disorder lie on a transdiagnostic 
spectrum with overlapping non-affective and affective psychotic symptoms.  
Methods: Multidimensional item response modelling was conducted on symptom ratings of the 
OPCRIT system in 1168 patients with schizophrenia spectrum and bipolar disorder.  
Results: A bifactor model with one general, transdiagnostic psychosis dimension underlying affective 
and non-affective psychotic symptoms and five specific dimensions of positive, negative, 
disorganized, manic, and depressive symptoms provided the best model fit and diagnostic utility for 
categorical classification.  
Conclusions: Our findings provide support for including dimensional approaches into classification 
systems and a directly measurable clinical phenotype for cross-disorder investigations into shared 
genetic and environmental factors of psychosis. 
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Introduction 
The dichotomy of dementia praecox/schizophrenia and manic depression has informed diagnostic 
classification in psychiatry ever since it was first proposed by Emil Kraepelin.
1
  While this dichotomy 
remains in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition  (DSM-5.0),
2
 the 
need for a dimensional approach to classification in psychiatry,
3
 and inclusion of such an approach in 
updated versions of DSM-5.0
4
 and the impending, eleventh revision of the International Classification 
of Diseases (ICD-11),
5
 continues to be debated in view of calls for research that looks across 
diagnostic categories
3,5
 and the persistent challenge of high comorbidity rates.
3-8 
 
In recent years, the Kraepelinian dichotomy has been challenged in light of evidence on common 
aetiological factors in schizophrenia and bipolar disorder.
9
 Evidence has accumulated that genetic 
risk is partly shared between schizophrenia and bipolar disorder.
9-12
 For instance, molecular genetic 
studies point to common DNA variants that impact on risk of both disorders.
11
 There is also evidence 
on shared environmental contributions to schizophrenia and bipolar disorder.
12
 These include 
prenatal factors,
13,14
 childhood adversity,
15
 substance misuse,
16,17
 urbanicity,
18,19
 and ethnicity.
19
 
These findings, taken together, challenge Kraepelin’s
1
 distinction between schizophrenia and bipolar 
disorder and their classification as separate diagnostic entities. Alternatively, Craddock and Owen
9
 
have proposed a transdiagnostic, mood-psychosis clinical dimension with three overlapping broad 
domains of psychopathology, namely schizophrenia, schizoaffective and bipolar disorder. 
 
However, there is also evidence on genetic and environmental risks that are not shared between 
schizophrenia and bipolar disorder. Family studies have consistently reported unique genetic 
contributions to schizophrenia and bipolar disorder.
12
 Findings further suggest some degree of 
specificity of environmental exposures.
8,18,19
 While, coupled with evidence on differences in course 
and outcome,
8
 these findings support the heterogeneity of psychotic disorders, it remains unclear 
which general and/or specific domains of the clinical psychosis phenotype will be most useful to 
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measure and map onto genetic and environmental factors and their underlying biological and 
psychological mechanisms.
9 
 
Intriguingly, empirical efforts to identify a more fundamental, transdiagnostic phenotype of psychosis 
at the clinical symptom level remain remarkably limited. While previous factor-analytic work has 
largely pointed toward a pentagonal model with five dimensions of positive symptoms, negative 
symptoms, cognitive disorganization, mania, and depression,
20
 we have recently reported evidence 
for a bifactor model that includes one general psychosis dimension underlying affective and non-
affective psychotic symptoms as well as five specific psychosis dimensions of positive symptoms, 
negative symptoms, disorganization, mania, and depression.
21
 However, findings were restricted to 
samples of schizophrenia spectrum disorder and the clinical symptom measure (i.e., the Positive and 
Negative Syndrome Scale) not directly linked to existing diagnostic classification systems. Also, in 
contrast to our recent finding, Russo et al.
22
 reported a model with two distinct factors for non-
affective and affective psychosis. Empirical evidence on general and/or specific symptom dimensions, 
and their diagnostic utility, in both schizophrenia spectrum and bipolar disorder may help psychiatry 
move toward diagnostic approaches that better match shared and non-shared genetic and 
environmental risks, on the basis of which treatment and prognosis can be optimised. In this study, 
we aimed to investigate whether schizophrenia spectrum and bipolar disorders lie on a 
transdiagnostic spectrum with overlapping non-affective and affective psychotic symptoms using a 
symptom measure that can be directly used for making clinical diagnosis, i.e., the OPerational 
CRITeria (OPCRIT) system.
23
 To this end, we sought to examine: a) whether the previously identified 
general psychosis dimension holds across diagnostic categories of schizophrenia spectrum and 
bipolar disorders; b) whether formation of specific psychosis dimensions is justified in addition to a 
general psychosis dimension; c) the diagnostic utility of general and specific psychosis dimensions for 
classifying patients correctly into categorical diagnoses of psychotic disorders; and d) associations 
between clinical variables and general and specific psychosis dimensions. 
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Method 
Sample 
We analysed a pooled sample obtained from the UK700 study
24
 and the Bipolar Association Case-
Control Study (BACCS).
25
 Patients in the UK700 study were recruited between 1994 and 1996 from 
four UK inner-city mental health services in London and Manchester using the following inclusion 
criteria: 1) aged between 18 and 65 years; 2) a psychotic illness for at least 2 years. A total of 708 
patients were recruited during the study period. Of these, 691 patients with a diagnosis of 
schizophrenia (n=345), schizoaffective disorder (n=270), mania/bipolar disorder (n=34), and 
unspecified functional psychoses (n=42) were included into the current study. Patients with a 
diagnosis of major depression (n=16) or without diagnosis (n=1) were excluded.  
 
Patients for the BACCS study
25
 were recruited between 2004 and 2007 from the greater London area, 
UK, through out-patient psychiatric clinics, self-help groups, and media advertisements. Inclusion 
criteria were: 1) aged over 18 years; 2) at least two episodes of illness, at least one of which fulfilled 
diagnostic criteria for mania/hypomania. During the study period, a total of 512 patients were 
recruited at the London site. Of these, 477 patients with a current diagnosis of mania/bipolar 
disorder (n=332), hypomania (n=143), and unspecified functional psychosis (n=2) were included in 
the current study. Patients with a current diagnosis of major depression (n=2) and current 
unspecified diagnosis (n=33) were excluded. More detailed information including ethical approval for 
all relevant aspects of the studies is available in Burns et al.
24
 and Cohen-Woods et al.
25
. The two 
samples were combined in a pooled sample to achieve both sufficient numbers in each diagnostic 
group and a sufficient prevalence of individual symptoms for item response model analysis to be 
performed. 
 
Measures 
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The OPCRIT system was used to assess psychiatric symptoms as described by McGuffin et al.
23
 
OPCRIT consists of a 90-item checklist that allows for structured examination of basic demographic 
information, disease course and severity (including age at onset, mode of onset, premorbid 
adjustment), and psychotic symptoms based on all available sources including case records, clinical 
and research interviews. It provides definitions for each item and algorithms for objective diagnosis 
of non-affective and affective psychotic disorders based on a range of diagnostic classification 
systems. A detailed description of the use of OPCRIT in the BACCS and UK700 study is provided in 
Appendix DS1 in the online data supplement. For the purposes of this study, psychiatric diagnosis 
was made based on the Research Diagnostic Criteria (RDC) using the OPCRIT system (26), which has 
been found to be both feasible and reliable in research settings and recently been redesigned for use 
in clinical settings (i.e., OPCRIT+).
23,27
 We used all OPCRIT items with sufficient prevalence of 
psychotic symptoms (>10%) in the pooled sample for item response model analysis. 
 
Statistical analysis 
Multidimensional item response modeling was conducted using the mirt package of the R 
environment
28
 for model estimation. We assumed data to be missing at random, which allowed for 
inclusion of the full sample. We examined model fit using the log-likelihood (LL), the Akaike 
Information Criterion (AIC), Bayesian Information Criterion (BIC), and the Sample-size Adjusted BIC 
(SABIC).
29
 For these fit statistics, lower values than for the comparison model indicate a statistically 
better model fit. In order to examine whether there is a general psychosis dimension and, in 
addition, whether there are 5 specific symptom dimensions (positive symptoms, negative symptoms, 
disorganization, mania, depression), we estimated five alternative item response models (Figure 
DS1): first, a simple unidimensional model with 1 general factor explaining all OPCRIT symptom 
ratings (model A; corresponding to a unitary psychosis model); second, a multidimensional model 
with 5 uncorrelated specific factors for each specific symptom dimension (model B); third, a 
multidimensional model with 5 correlated specific factors (model C; corresponding, as model B, to 
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the pentagonal model of psychosis
20
); fourth, a bifactor model with 2 distinct factors for affective and 
non-affective psychosis and 5 uncorrelated factors for each specific symptom dimension (model D; 
corresponding to the Russo et al.
22
 model) and, fifth, a bifactor model with 1 general factor 
independent from 5 uncorrelated (orthogonal) specific factors (Model E; corresponding to the 
bifactor model reported in our earlier study of patients with schizophrenia spectrum disorder
21
). The 
procedure for fitting these models in the context of psychotic symptom ratings have been described 
in more detail elsewhere.
21
 Importantly, the bifactor model with 1 general and 5 specific factors 
constrained each OPCRIT item to have a nonzero loading on the general factor (i.e., psychosis) and a 
nonzero loading on a specific factor (e.g., positive symptoms) to examine whether there is a general 
dimension underlying symptoms of schizophrenia spectrum and bipolar disorder independent from 
(i.e., non-redundant with) the previously reported specific symptom dimensions. In order to examine 
the extent to which factor scores of general and specific psychosis dimensions (as predictor variable) 
allow for accurate classification of patients into diagnostic categories (as outcome variable), 
multinomial Receiver Operating Characteristic (ROC) analysis
30
 were conducted in Stata version 12.
31
 
Finally, we used linear regression to investigate associations between clinical variables (including age 
at onset, mode of onset, premorbid work adjustment, and premorbid social adjustment) and factor 
scores of general and specific psychosis dimensions. 
 
Results 
Basic sample characteristics 
Basic sample characteristics of the pooled sample of 1168 patients are summarised in Table DS1 in 
the online data supplement. The mean age at interview was 42.1 years and approximately half were 
female (n=608, 52.1%). The mean age at illness onset was 22.2 years. The most common diagnosis 
was mania/bipolar disorder (31.3%), followed by schizoaffective disorder (29.5%) and schizophrenia 
(23.1%). As can be seen in Table DS2 in the online data supplement, the prevalence of psychotic 
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symptoms was sufficient in the pooled sample for item response model analysis. Consistent with 
inclusion criteria, we observed differences in prevalence of symptoms across studies. 
 
Dimensionality of schizophrenia spectrum and bipolar disorder 
Model fit statistics for the five alternative dimensional models of schizophrenia spectrum and bipolar 
disorder are shown in Table 1. The best model fit was consistently observed across model fit statistics 
for the bifactor model including 1 general and 5 specific symptom factors as compared with all other 
models. This indicated that there was a general psychosis dimension that explained associations 
among all symptoms of schizophrenia spectrum and bipolar disorder as well as that, over and above 
this general psychosis dimension, the formation of 5 specific psychosis dimensions was justified. 
 
[Insert Table 1 here] 
 
Association of symptom ratings with general and specific psychosis dimensions  
Table 2 shows standardized factor loadings for the best-fitting model including one general and five 
specific psychosis dimensions. Factor loadings on the general psychosis factor were moderate to 
strong for most OPCRIT symptom ratings. OPCRIT ratings of manic symptoms were inversely related 
to the underlying general psychosis dimension. By contrast, factor loadings of almost all other ratings 
were in the positive range. Coupled with findings on model fit statistics reported above, this 
indicated that there is a general psychosis dimension underlying affective and non-affective 
psychotic symptoms that holds across schizophrenia spectrum and bipolar disorder. We further 
found weak to moderate factor loadings of OPCRIT ratings on the specific positive, negative and 
disorganized symptom factor. OPCRIT ratings of manic and depressive symptoms were moderately to 
strongly associated with the underlying specific symptom dimensions. These findings were first 
probed in a sensitivity analysis to examine replicability of findings by a bootstrap procedure (Table 
DS3 in the online data supplement). For those parameters for which some relevant bias was 
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detected, absolute values of parameters were estimated to be even larger than the respective point 
estimate. 
 
[Insert Table 2 here] 
 
Diagnostic utility of general and specific psychosis dimensions  
All latent factor scores were strongly and positively associated with weighted OPCRIT sum scores for 
general and specific psychosis dimensions (Table 3). This indicated that higher weighted sum scores 
on a particular dimension can be interpreted as representations of higher latent factor scores.  
 
[Insert Table 3 here] 
 
Symptom profiles for, and findings on differences in, general and specific psychosis dimensions by 
diagnostic categories are shown in Figure 1 and Table 3, respectively. Scores on the general psychosis 
(R
2
=0.81), specific positive (R
2
=0.04), negative (R
2
=0.02), and disorganized (R
2
=0.05) symptom 
dimensions were higher for categorical diagnoses of schizophrenia and schizoaffective disorder 
compared with bipolar disorder. On the manic symptom dimension, scores were lower for 
schizophrenia than for bipolar disorder (R
2
=0.20). Compared with bipolar disorder, scores on the 
depressive symptom dimension were higher for schizoaffective disorder and lower for schizophrenia 
(R
2
=0.18). 
 
[Insert Figure 1 here] 
 
We next examined the utility of general and specific psychosis dimensions for predicting categorical 
diagnoses using multinomial ROC analysis. Findings on classifying patients into diagnostic categories 
based on general psychosis dimension compared with classifying patients by chance are shown in 
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Figure DS2 in the online data supplement. Factor scores of the general psychosis dimension yielded a 
higher proportion of correctly classified patients than each of the specific symptom dimensions alone 
(Figure DS2a). However, the proportion of patients correctly classified into diagnostic categories 
based on factor scores of both general and specific psychosis dimensions was markedly higher (95% 
CI 0.69-0.79) than the proportions based on the general psychosis dimension only (95% CI 0.45-0.63), 
all specific psychosis dimensions combined (95% CI 0.46-0.57), and what would be expected by 
chance (95% CI 0.24-0.35) (Figure DS2b). Table DS4 in the online data supplement shows 
corresponding findings from the multinomial regression model with the highest classification 
accuracy including both general and specific psychosis dimensions for predicting categorical 
diagnoses. 
 
General and specific psychosis dimensions by clinical variables 
Finally, we examined general and specific psychosis dimensions in relation to clinical variables. 
Findings on factors scores of general and specific psychosis dimensions by age at onset, mode of 
onset, premorbid work and social adjustment are shown in Table 3. Scores on the general psychosis 
dimension were significantly higher for patients with a later age at onset, gradual and insidious (vs. 
acute) mode of onset, poor premorbid work and social adjustment. Table 3 further shows that, 
compared with patients with an acute onset, those with an insidious onset had lower scores on the 
positive symptom dimension and higher scores on the negative and depressive symptom dimension. 
Higher scores on the positive, negative, and disorganized symptom dimension and lower scores on 
the manic symptom dimension were found in patients with poor premorbid work adjustment. 
Patients with poor premorbid social adjustment also scored higher on the negative and disorganized 
symptom dimension than those with good premorbid social adjustment. 
 
Discussion 
Principal findings 
U Reininghaus 
11 
 
This study is the first to provide evidence for a general psychosis dimension underlying affective and 
non-affective psychotic symptoms that holds across schizophrenia spectrum and bipolar disorder. 
Further, there was evidence to suggest formation of specific psychosis dimensions of positive 
symptoms, negative symptoms, disorganization, mania, and depression is justified. Symptom profiles 
revealed that general and specific psychosis dimensions discriminated well between, and were 
consistent with the typical clinical picture of, categorical diagnoses of psychotic disorders. We also 
found strong evidence on the diagnostic utility when using both general and specific psychosis 
dimensions for predicting categorical diagnoses. Finally, there was evidence that general and specific 
psychosis dimensions were differentially associated with age at onset, mode of onset, premorbid 
work and social adjustment. 
 
Methodological considerations 
We investigated the dimensionality of psychosis in a pooled sample of patients with schizophrenia, 
schizoaffective disorder, bipolar disorder, hypomania, and unspecified functional psychosis. While 
this sample allowed for multidimensional item response modelling of psychotic symptom ratings 
using a clinical measure directly linked to existing diagnostic classification systems, we were able to 
include only 3 OPCRIT items with sufficient prevalence (>10%) on negative symptoms, resulting in 
reduced coverage of this domain, which likely accounted for the limited predictive value of this 
dimension for categorical diagnoses. Further, given these restrictions on prevalence, the pooled 
sample size did not provide sufficient power for cross-validation of findings. However, single cross-
validations are known to make inefficient use of the data.
32
 Therefore, we used a bootstrap 
procedure,
33
 providing good evidence on the replicability of findings (Table DS3).  Differences in 
inclusion criteria, OPCRIT rating procedure (Appendix DS1), and prevalence of symptoms (Table DS2) 
across the two studies, which we purposefully combined in order to achieve sufficient spread in the 
distribution of non-affective and affective psychotic symptoms, may have led to an artificial increase 
in variance of both manifest symptoms and latent variables.
34
 Even though difficult to disentangle in 
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this study, we would argue that, given OPCRIT is a well-validated tool purposefully designed to allow 
flexibility in its use (Appendix DS1)
23,27,42
 as well as the underlying commonalities in phenomenology, 
aetiology, and severity of schizophrenia and bipolar spectrum disorder, such an increase in variance 
was unlikely to be artificial and instead allowed us to cover a broad range of psychotic disorders. 
However, ultimately, further investigations that purposefully sample across diagnoses with the same 
diagnostic assessment methodology are warranted to more fully elucidate this question.
3
 Finally, the 
current study did not include patients with other relevant non-psychotic disorders, which would have 
helped to disentangle overlap with, or independence from, other important spectra of mental 
disorder.
4,9,34
 Multidimensional item response modelling allowed us to advance on previous research 
investigating the dimensionality of psychosis by identifying latent dimensions as determinants of 
symptoms. This approach is now widely considered preferable (e.g. over principal component 
analysis), let alone, ignoring the dimensional structure and factorial validity of symptom measures 
altogether, as common causes and liabilities plausibly lead to symptoms, and not vice versa.
34
 It is 
also noteworthy that the bifactor model with 1 general and 5 specific factors consistently provided a 
better model fit even when compared with models requiring estimation of the same number of free 
parameters and, therefore, of identical parsimony.
22 
 
Comparisons with previous research 
Recent years have seen calls for research cutting across boundaries of diagnostic categories, in order 
to strengthen the evidence base for including dimensional approaches in updated versions of DSM-
5.0.
3,4,9
 Our finding of a general psychosis dimension provides evidence, at the clinical symptom level, 
that cuts across boundaries of the Kraepelinian dichotomy and suggests that schizophrenia and 
bipolar disorder lie on a transdiagnostic psychosis spectrum with overlapping non-affective and 
affective symptoms. When directly compared with a model with two distinct factors for non-affective 
and affective psychosis (a model of identical parsimony),
22
 a superior fit was evident for the bifactor 
model including 1 general psychosis factor (and 5 specific symptom factors). This extends our 
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previous finding of a general psychosis dimension
21
 in schizophrenia spectrum disorder to individuals 
with bipolar disorder. This dimension resembles, to a degree, the thought disorder factor reported by 
previous studies,
7,35
 however, the thought disorder factor also included other disorders such as 
schizotypal and schizoid personality disorders or obsessive-compulsive disorders.
7,35
 Consistent with 
numerous previous studies,
20,21
 there was also evidence that, in addition to this dimension, psychotic 
symptom ratings are best accounted for by 5 specific dimensions of positive symptoms, negative 
symptoms, disorganization, mania, and depression.  
 
In recent years, some researchers have proposed combining dimensional and categorical approaches 
in the classification of mental disorders,
4,20
 such as ICD-11
5
 and (updated versions of) the DSM-5.0.
2
 
However, to date, there has only been very limited evidence on the diagnostic utility of dimensional 
representations of psychosis for classifying patients into categorical diagnoses. Overall, strong 
diagnostic utility of the general and specific psychosis dimensions for allocating patients to diagnoses 
was demonstrated with the OPCRIT system, a clinical symptom measure that can be used to 
implement scoring algorithms in both research and routine care.
23,27
 Symptom profiles showed that 
the general psychosis dimension enabled individuals to be placed on the mania (bipolar 
disorder/hypomania) versus schizophrenia (schizoaffective disorder/schizophrenia) end of the 
psychosis spectrum. For the specific psychosis dimensions, symptom profiles were consistent with 
operational definitions of current classification systems
2,36
 and remarkably similar to those 
hypothesized for typical patients.
20
 Based on these findings, specific scoring rules can be defined and 
implemented that allow more accurate classification of patients into these diagnoses. Our findings on 
symptom profiles may provide a basis for such an approach (Figure DS3): first, quantitative scores on 
the general psychosis dimension may be used to determine whether to place patients on the mania 
or schizophrenia end of the psychosis spectrum; in a second step, based on the profiles for specific 
symptom dimensions, patients may be classified into specific diagnoses.  
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Findings on differential associations between clinical variables and general and specific psychosis 
dimensions echoed previous reports.
7,20,21,37
 A later, more insidious mode of onset and a poorer 
premorbid adjustment were associated with the non-affective end of the psychosis spectrum, 
whereas an earlier, more acute mode of onset and a better premorbid adjustment related to the 
affective end of the psychosis spectrum (Figure DS3). A similar pattern was also evident for the 
relationship between these variables and the specific symptom dimensions. There is growing 
evidence that genetic variation and environmental exposures are shared across diagnostic 
categories.
11,12
 Using the OPCRIT system to derive RDC diagnosis in a twin study, Cardno et al.
10
 found 
evidence of both common and syndrome-specific genetic contributions to psychosis liability. Given 
also recent calls for identifying cross-cutting dimensions,
3,4
 it is intriguing to speculate whether the 
general schizophrenia-bipolar disorder psychosis dimension that we have identified here might be 
strongly linked to shared genetic and environmental risks,
9-19,37-39
 whereas the specific psychosis 
dimensions are associated with non-shared risks. While a few studies have investigated intermediate 
and clinical phenotypes across several different psychotic disorders,
40
 to date, no study that we are 
aware of has identified and validly measured a transdiagnostic, clinical phenotype of general 
psychosis underlying affective and non-affective psychotic symptoms in schizophrenia and bipolar 
disorders. However, ultimately, such a measure, as provided here, is required if we are to move from 
intermediate to clinical phenotypes and study these in relation to course and outcome of psychosis. 
 
Conclusions 
Our findings suggest that schizophrenia spectrum and bipolar disorders lie on a transdiagnostic 
psychosis spectrum with overlapping affective and non-affective psychotic symptoms. Coupled with 
strong evidence on diagnostic utility, this finding should inform inclusion of dimensional approaches 
into (updated versions of) the DSM and may substantially enhance classification accuracy of current 
diagnostic classification systems. Our findings also provide a directly measurable clinical phenotype 
for cross-disorder investigations into genetic and environmental factors of psychosis. These are now 
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required to identify shared genetic and environmental contributions to this phenotype (as well as 
non-shared factors of specific psychosis dimensions) and to disentangle potential overlap with, or 
independence from, other important spectra of mental disorder.   
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Table 1. Model fit statistics unidimensional, multidimensional, and bifactor models in schizophrenia spectrum and bipolar disorder 
 Full information fit statistics† 
 
LL FP AIC BIC SABIC 
Unidimensional (unitary) model (A) -24624.19 98 49444.39 49940.57 49629.29 
Multidimensional (pentagonal) model with 
uncorrelated factors (B) 
-23585.87 98 47367.74 47863.92 47552.64 
Multidimensional (pentagonal) model with 
correlated factors (C) 
-22468.5 108 45153.00 45175.23 45356.76 
Bifactor model with 2 factors for affective 
and non-affective psychosis and 5 specific 
symptom factors (D) 
-22539.24 147 45372.49 46116.75 45415.14 
Bifactor model with 1 general psychosis and 
5 specific symptom factors (E) 
-22058.87 147 44411.75 45156.02 44689.09 
Note: LL, Log-Likelihood; FP, Free Parameters; AIC, Akaike Information Criterion; BIC, Bayesian Information Criterion; SABIC, Sample size Adjusted  
Bayesian Information Criterion 
† A difference of 10 in AIC, BIC, and SABIC is considered important 
‡ The best model fit was still observed for model E as compared with a bifactor model, in which factor loadings of mania items on the  
general factor were fixed to zero and the specific mania factor correlated with the general and other specific factors (LL=-22104.99, AIC=44491.98,  
BIC=45205.87, SABIC=44758.01; r
general-mania
=-0.68, r
positive-mania
=-0.14; r
negative-mania
=-0.27; r
disorganization-mania
=0.21; r
mania-depression
=0.15) 
 
 
Table 2. Standardized factor loadings in bifactor model 
OPCRIT Items Item no. 
Factor loadings 
h
2 
General 
Positive  
symptoms 
Negative 
symptoms 
Disorganization Mania Depression 
Persecutory delusions 54 0.90 0.21     0.86 
Well organised delusions 55 0.93 -0.08     0.88 
Delusions of influence 58 0.31 0.44     0.29 
Bizarre delusions 59 0.91 -0.05     0.84 
Widespread delusions 60 0.97 -0.06     0.94 
Delusions of passivity 61 0.78 0.37     0.74 
Delusions & hallucinations for 1 week 64 0.91 0.34     0.94 
Persecutory delusions & hallucinations 65 0.91 0.30     0.91 
Thought insertion 66 0.74 0.55     0.84 
Thought withdrawal 67 0.80 0.42     0.82 
Thought broadcast 68 0.72 0.49     0.76 
Third person auditory hallucinations 73 0.78 0.40     0.77 
Running commentary voices 74 0.67 0.45     0.65 
Abusive/accusatory/persecutory voices 75 0.83 0.30     0.78 
Other auditory hallucinations 76 0.77 0.02     0.59 
Non-affective hallucination any modality 77 0.79 0.13     0.64 
Negative formal thought disorder 29 0.77  0.35    0.71 
Restricted affect 32 0.81  0.42    0.82 
Blunted affect 33 0.84  0.42    0.88 
Bizarre behaviour 17 0.82   0.28   0.75 
Speech difficult to understand 26 0.76   0.57   0.91 
Incoherent 27 0.70   0.65   0.91 
Positive formal thought disorder 28 0.80   0.48   0.87 
Inappropriate affect 34 0.73   0.25   0.59 
Excessive activity 19 -0.56    0.66  0.75 
Reckless activity 20 -0.31    0.54  0.39 
Distractibility 21 -0.34    0.62  0.50 
Reduced need for sleep 22 -0.63    0.61  0.76 
Pressured speech 30 -0.58    0.68  0.81 
Thoughts racing 31 -0.72    0.62  0.89 
Elevated mood 35 -0.73    0.61  0.90 
Irritable mood 36 -0.01    0.54  0.29 
Increased sociability 53 -0.54    0.63  0.68 
Increased self esteem 56 -0.51    0.65  0.69 
Grandiose delusions 57 -0.09    0.66  0.45 
Slowed activity 24 0.54     0.62 0.67 
Loss of energy/tiredness 25 0.56     0.70 0.81 
Dysphoria 37 0.65     0.61 0.80 
Loss of pleasure 39 0.51     0.76 0.84 
Altered libido 40 0.49     0.67 0.69 
Poor concentration 41 0.47     0.61 0.59 
Excessive self reproach 42 0.36     0.80 0.78 
Suicidal ideation 43 0.64     0.54 0.70 
Initial insomnia 44 0.29     0.58 0.42 
Middle insomnia (broken sleep) 45 0.46     0.53 0.50 
Early morning waking 46 0.07     0.69 0.48 
Poor appetite 48 0.00     0.61 0.37 
Weight loss 49 -0.21     0.55 0.34 
Increased appetite 50 -0.28     0.05 0.08 
 
Table 3. Factors scores of general and specific symptom dimensions by clinical variables 
 Latent factor scores 
 General  Positive symptoms  Negative symptoms  Disorganisation  Mania  Depression 
 r (95% CI) p  r (95% CI) p  r (95% CI) p  r (95% CI) p  r (95% CI) p  r (95% CI) p 
OPCRIT weighted sum scores†                  
 General 
0.93 
(0.92-0.94) 
<0.001                
 Positive symptoms    
0.77 
(0.74-0.79) 
<0.001             
 Negative symptoms       
0.78 
(0.76-0.80) 
<0.001          
 Disorganization          
0.67 
(0.64-0.70) 
<0.001       
 Mania             
0.81 
(0.79-0.83) 
<0.001    
 Depression                
0.87 
(0.86-0.89) 
<0.001 
 B (95% CI) p  B (95% CI) p  B (95% CI) p  B (95% CI) p  B (95% CI) p  B (95% CI) p 
RDC diagnosis‡                  
 Hypomania  
-0.15 
(-0.23 - -0.08) 
<0.001  
0.04 
(-0.08-0.16) 
0.551  
0.01 
(-0.08-0.10) 
0.848  
-0.01 
(-0.11-0.10) 
0.907  
-0.44 
(-0.57 - -0.31) 
<0.001  
-0.20 
(-0.33 - -0.06) 
0.005 
 Schizoaffective disorder  
1.50 
(1.45-1.56) 
<0.001  
0.16 
(0.07-0.26) 
<0.001  
0.10 
(0.04-0.17) 
0.002  
0.25 
(0.17-0.33) 
<0.001  
-0.05 
(-0.15-0.05) 
0.292  
0.44 
(0.34 - 0.55) 
<0.001 
 Schizophrenia 
1.50 
(1.44-1.56) 
<0.001  
0.30 
(0.20-0.40) 
<0.001  
0.14 
(0.07-0.21) 
<0.001  
0.14 
(0.06-0.23) 
0.001  
-0.73 
(-0.84 - -0.63) 
<0.001  
-0.46 
(-0.57 - -0.35) 
<0.001 
 Unspecified functional psychosis 
1.27 
(1.15-1.39) 
<0.001  
-0.01 
(-0.21-0.18) 
0.904  
0.13 
(-0.01-0.28) 
0.063  
-0.15 
(-0.32-0.02) 
0.075  
-0.99 
(-1.20 - -0.78) 
<0.001  
0.04 
(-0.18 - 0.26) 
0.716 
Age at onset 
0.03 
(0.02-0.03) 
<0.001  
0.00 
(-0.00-0.00) 
0.821  
0.00 
(-0.00-0.00) 
0.666  
-0.00 
(-0.01-0.00) 
0.123  
-0.01 
(-0.01- -0.00) 
<0.001  
0.00 
(-0.00-0.01) 
0.190 
Mode of onset                  
 Gradual vs. acute onset 
0.40 
(0.25-0.56) 
<0.001  
0.05 
(-0.07-0.16) 
0.407  
0.03 
(-0.05-0.11) 
0.491  
-0.03 
(-0.13-0.07) 
0.561  
0.002 
(-0.13-0.14) 
0.982  
0.06 
(-0.09-0.20) 
0.440 
 Insidious vs. acute onset 
0.24 
(0.11-0.36) 
<0.001  
-0.10 
(-0.19- -0.01 
0.037  
0.17 
(0.11-0.24) 
<0.001  
-0.07 
(-0.15-0.01) 
0.084  
-0.03 
(-0.14-0.07) 
0.546  
0.12 
(0.003-0.23) 
0.045 
Premorbid work adjustment                  
 Poor vs. good 
0.86 
(0.74-0.97) 
<0.001  
0.11 
(0.02-0.20) 
0.018  
0.15 
(0.09-0.22) 
<0.001  
0.23 
(0.15-0.31) 
<0.001  
-0.13 
(-0.24 - -0.02) 
0.016  
-0.00 
(-0.12-0.11) 
0.936 
Premorbid social adjustment                  
 Poor vs. good 
0.48 
(0.34-0.60) 
<0.001  
0.07 
(-0.02-0.16) 
0.144  
0.08 
(0.01-0.14) 
0.023  
0.21 
(0.13-0.29) 
<0.001  
-0.06 
(-0.17-0.04) 
0.235  
0.07 
(-0.04-0.18) 
0.198 
†OPCRIT sum scores were weighted using the sign of factor loadings in the bifactor model (see table 2) as (simplified) weights to account for negative factor loadings on general and positive symptom dimensions 
(i.e., an item with a negative factor loading was subtracted, not added). Associations for latent factor scores of the general and specific positive symptom dimension (for which negative factor loadings were found in 
the bifactor model; see table 2) were markedly attenuated when using unweighted OPCRIT sum scores (general, r=0.67, 95% CI 0.64 to 0.71, p<0.001; positive symptoms, r=0.46, 95% CI 0.41 to 0.50, p<0.001). 
‡ Using bipolar disorder/mania as reference category 
Figure 1. Symptom profiles for general and specific psychosis dimensions by diagnosis (for publication in 
print)† 
 
 
† Explanatory Note: Symptom profiles are the mean factor scores for 1 general psychosis dimension and 5 specific psychosis 
dimensions (positive symptoms, negative symptoms, disorganization, mania, depression) by diagnostic categories 
(schizophrenia, schizoaffective disorder, hypomania, and bipolar disorder/mania). Factor scores are standardized with mean = 0 
and SD=1. Given negative factor loadings were found for mania items on the general psychosis dimension, patients with low 
ratings on all OPCRIT items are assigned a factor score close to the mean=0, whereas patients with high ratings on mania items 
but low ratings on other psychotic symptoms are assigned a negative factor score and patients with low ratings on mania items 
but high ratings on other psychotic symptoms are assigned a positive factor score. Symptom profiles showed high (positive) 
mean scores for schizophrenia on the general psychosis dimension as well as on the specific positive, negative, and 
disorganized symptom dimension, but low (negative) mean scores on the specific manic and depressive symptom dimension. 
There were also high (positive) mean scores on the general psychosis and specific positive, negative, and disorganized symptom 
dimension for schizoaffective disorder. However, on the specific manic symptom dimension, mean scores for schizoaffective 
disorders were higher than for schizophrenia and comparable to the mean scores of bipolar disorder/mania. Mean scores on 
the specific depressive symptom dimension were higher in schizoaffective disorder than in all other diagnostic categories. Low 
(negative) mean scores were found for bipolar disorder/mania and hypomania on the general psychosis dimension as well as on 
the specific positive, negative, disorganized, and depressive symptom dimension. However, compared with other diagnostic 
categories, mean scores were significantly higher on the specific mania dimension for these diagnoses. 
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the specific depressive symptom dimension were higher in schizoaffective disorder than in all other diagnostic categories. Low 
(negative) mean scores were found for bipolar disorder/mania and hypomania on the general psychosis dimension as well as on 
the specific positive, negative, disorganized, and depressive symptom dimension. However, compared with other diagnostic 
categories, mean scores were significantly higher on the specific mania dimension for these diagnoses.  
 
 
General psychosis
Positive symptoms
Negative symptoms
Disorganization
Mania
Depression
-.5
0
.5
1
Bipolar/Mania Schizoaffective
Hypomania Schizophrenia
